442 related articles for article (PubMed ID: 18586440)
21. Prognostic power of pre- and postoperative B-type natriuretic peptide levels in patients undergoing abdominal aortic surgery.
Vetrugno L; Costa MG; Pompei L; Chiarandini P; Drigo D; Bassi F; Gonano N; Muzzi R; Della Rocca G
J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):637-42. PubMed ID: 22387082
[TBL] [Abstract][Full Text] [Related]
22. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
[TBL] [Abstract][Full Text] [Related]
23. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
24. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
Bonaca MP; Wiviott SD; Sabatine MS; Buros J; Murphy SA; Scirica BM; Rifai N; Antman EM; Morrow DA
Am J Cardiol; 2007 Feb; 99(3):344-8. PubMed ID: 17261395
[TBL] [Abstract][Full Text] [Related]
25. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.
Chong CP; Lim WK; Velkoska E; van Gaal WJ; Ryan JE; Savige J; Burrell LM
Am J Cardiol; 2012 May; 109(9):1365-73. PubMed ID: 22381157
[TBL] [Abstract][Full Text] [Related]
26. Amino-terminal pro-brain natriuretic peptide as a predictor of outcome in patients admitted to intensive care. A prospective observational study.
De Geer L; Fredrikson M; Oscarsson A
Eur J Anaesthesiol; 2012 Jun; 29(6):275-9. PubMed ID: 22543574
[TBL] [Abstract][Full Text] [Related]
27. A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients.
Rodseth RN; Padayachee L; Biccard BM
Anaesthesia; 2008 Nov; 63(11):1226-33. PubMed ID: 18673363
[TBL] [Abstract][Full Text] [Related]
28. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock.
Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y
Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555
[TBL] [Abstract][Full Text] [Related]
29. N-terminal-pro-BNP in critically ill patients with acute respiratory failure: a prospective cohort study.
Okkonen M; Varpula M; Linko R; Perttilä J; Varpula T; Pettilä V;
Acta Anaesthesiol Scand; 2011 Jul; 55(6):749-57. PubMed ID: 21480833
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke.
Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL
Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362
[TBL] [Abstract][Full Text] [Related]
31. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
[TBL] [Abstract][Full Text] [Related]
32. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
Kragelund C; Grønning B; Køber L; Hildebrandt P; Steffensen R
N Engl J Med; 2005 Feb; 352(7):666-75. PubMed ID: 15716560
[TBL] [Abstract][Full Text] [Related]
33. N-terminal pro-B-type natriuretic peptide is an independent predictor of all-cause mortality and MACE after major vascular surgery in medium-term follow-up.
Rajagopalan S; Croal BL; Reeve J; Bachoo P; Brittenden J
Eur J Vasc Endovasc Surg; 2011 May; 41(5):657-62. PubMed ID: 21330158
[TBL] [Abstract][Full Text] [Related]
34. Baseline natriuretic peptide levels in relation to myocardial ischemia, troponin T release and heart rate variability in patients undergoing major vascular surgery.
Feringa HH; Vidakovic R; Karagiannis SE; de Jonge R; Lindemans J; Goei D; Schouten O; Bax JJ; Poldermans D
Coron Artery Dis; 2007 Dec; 18(8):645-51. PubMed ID: 18004116
[TBL] [Abstract][Full Text] [Related]
35. Does preoperative B-type natriuretic peptide better predict adverse outcome and prolonged length of stay than the standard European System for Cardiac Operative Risk Evaluation after cardiac surgery?
Fellahi JL; Daccache G; Rubes D; Massetti M; Gérard JL; Hanouz JL
J Cardiothorac Vasc Anesth; 2011 Apr; 25(2):256-62. PubMed ID: 20674395
[TBL] [Abstract][Full Text] [Related]
36. Troponin I and NT-proBNP (N-terminal pro-brain natriuretic peptide) do not predict 6-month mortality in frail older patients undergoing orthopedic surgery.
Chong CP; van Gaal WJ; Ryan JE; Burrell LM; Savige J; Lim WK
J Am Med Dir Assoc; 2010 Jul; 11(6):415-20. PubMed ID: 20627182
[TBL] [Abstract][Full Text] [Related]
37. N-Terminal pro B-type natriuretic peptide testing for short-term prognosis in breathless older adults.
Chenevier-Gobeaux C; Allo JC; Arthaud M; Achkar R; Claessens YE; Ekindjian OG; Riou B; Ray P
Am J Emerg Med; 2008 Jun; 26(5):555-60. PubMed ID: 18534284
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
Grewal J; McKelvie RS; Persson H; Tait P; Carlsson J; Swedberg K; Ostergren J; Lonn E
Am J Cardiol; 2008 Sep; 102(6):733-7. PubMed ID: 18773998
[TBL] [Abstract][Full Text] [Related]
39. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
[TBL] [Abstract][Full Text] [Related]
40. Plasma NT-proBNP levels and the risk of atrial fibrillation after major lung resection.
Gurgo AM; Ciccone AM; D'Andrilli A; Ibrahim M; Musumeci B; Quarta G; Saponaro A; Rendina EA; Volpe M
Minerva Cardioangiol; 2008 Dec; 56(6):581-5. PubMed ID: 19092733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
